MARKET

DARE

DARE

Dare Bioscience Inc
NASDAQ
2.890
+0.010
+0.35%
After Hours: 2.930 +0.04 +1.37% 18:19 05/13 EDT
OPEN
2.880
PREV CLOSE
2.880
HIGH
2.920
LOW
2.880
VOLUME
13.43K
TURNOVER
--
52 WEEK HIGH
7.56
52 WEEK LOW
2.670
MARKET CAP
25.58M
P/E (TTM)
-6.0587
1D
5D
1M
3M
1Y
5Y
1D
Dare Bioscience, Inc. (DARE) Reports Q1 Loss, Lags Revenue Estimates
NASDAQ · 3h ago
Dare Bioscience reports Q1 EPS (50c), consensus (58c)
TipRanks · 4h ago
Dare Bioscience GAAP EPS of -$0.50 beats by $0.08, revenue of $25.42M
Seeking Alpha · 4h ago
DARÉ BIOSCIENCE REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES COMPANY UPDATE
Reuters · 4h ago
*Dare Bioscience 1Q Loss/Shr 50c >DARE
Dow Jones · 4h ago
Press Release: Daré Bioscience Reports First Quarter 2025 Financial Results and Provides Company Update
Dow Jones · 4h ago
Press Release: Daré Bioscience Reports First -3-
Dow Jones · 4h ago
Here are the major earnings after the close today
Seeking Alpha · 10h ago
More
About DARE
More
Dare Bioscience, Inc. is a biopharmaceutical company committed to advancing products for women's health. XACIATO, the Company's United States Food and Drug Administration (FDA)-approved product, vaginal gel 2%, a lincosamide antibacterial indicated for the treatment of bacterial vaginosis in female patients 12 years of age and older, which is under a global license agreement with Organon. Its clinical-stage programs include Ovaprene; Sildenafil Cream, 3.6%; DARE-HRT1; DARE-VVA1; DARE-CIN; DARE-PDM1; DARE-204 and DARE-214, and DARE-FRT1 and DARE-PTB1. Its pre-clinical stage programs include DARE-LARC1, DARE-LBT, DARE-GML, DARE-RH1 and DARE-PTB2. Ovaprene, is a hormone-free monthly intravaginal contraceptive. Sildenafil Cream, 3.6%, is a cream formulation of sildenafil, the active ingredient in Viagra, to treat female sexual arousal disorder (FSAD). DARE-HRT1, is a combination bio-identical estradiol and progesterone intravaginal ring for menopausal hormone therapy.
Recently
Symbol
Price
%Change

Webull offers Dare Bioscience Inc stock information, including NASDAQ: DARE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DARE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DARE stock methods without spending real money on the virtual paper trading platform.